RecruitingNot Applicable

Multimodal Investigation of Intracranial Clot Environment

France200 participantsStarted 2021-03-14

Plain-language summary

Analysis of peri clot blood collected at the acute phase of stroke in order to understand physiopathological mechanisms involved in the cerebrovascular damage

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Over 18 years of age,
✓. Non-dependent for activities of daily living prior to the onset of the MI (Modified Rankin Score \>2)
✓. Having an occlusion of a large arterial trunk proven by imaging (angio-MRI or angio-scanner).

Exclusion criteria

✕. Patients initially admitted but for whom endovascular treatment will not finally be performed (re-infusion, catheterization failure...) will be excluded from the study.
✕. Major patients under guardianship or curatorship or patients deprived of liberty

What they're measuring

Metalloproteinase 9 quantification

Timeframe: 60 months

Metalloproteinase 2 quantification

Timeframe: 60 months

Trial details

NCT IDNCT04421326

SponsorUniversity Hospital, Montpellier

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-06

Contact for this trial

Cyril DARGAZANLI, MD MSc

467337532 c-dargazanli@chu-montpellier.fr

View on ClinicalTrials.gov More Acute Ichemic Stroke trials